Search research articles
Contact Us
Filters
Showing results (181-190 of 190) with videos related to
Page
of 19
Sort By:
You have reached the last page of results.
This site can display upto 190 results.
Bioorganic & Medicinal Chemistry
|
May 16, 2006
Synthesis and evaluation of 5,5-diphenylimidazolones as potent human neuropeptide Y5 receptor antagonists
Kevin W Gillman, Mendi A Higgins, Graham S Poindexter, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 30, 2009
Conformationally restricted homotryptamines. Part 5: 3-(trans-2-aminomethylcyclopentyl)indoles as potent selective serotonin reuptake inhibitors
Derek J Denhart, Jeffrey A Deskus, Jonathan L Ditta, et al.
Journal of Medicinal Chemistry
|
October 19, 2010
Conformationally restricted homotryptamines. Part 7: 3-cis-(3-aminocyclopentyl)indoles as potent selective serotonin reuptake inhibitors
H Dalton King, Zhaoxing Meng, Jeffrey A Deskus, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 21, 1998
Etoposide in malignant pleural mesothelioma: two phase II trials of the EORTC Lung Cancer Cooperative Group
T Sahmoud, P E Postmus, C van Pottelsberghe, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 30, 2007
Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors
Jeffrey A Deskus, James R Epperson, Charles P Sloan, et al.
Journal of Medicinal Chemistry
|
September 16, 2005
Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors
Ronald J Mattson, John D Catt, Derek J Denhart, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 4, 2007
Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor
H Dalton King, Derek J Denhart, Jeffrey A Deskus, et al.
ACS Medicinal Chemistry Letters
|
April 21, 2016
Discovery and Optimization of Macrocyclic Quinoxaline-pyrrolo-dihydropiperidinones as Potent Pim-1/2 Kinase Inhibitors
Victor J Cee, Frank Chavez, Bradley Herberich, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 27, 2012
[18F](R)-5-chloro-1-(1-cyclopropyl-2-methoxyethyl)-3-(4-(2-fluoroethoxy)-2,5-dimethyl phenylamino)pyrazin-2(1H)-one: introduction of N3-phenylpyrazinones as potential CRF-R1 PET imaging agents
Jeffrey A Deskus, Douglas D Dischino, Ronald J Mattson, et al.
Journal of Medicinal Chemistry
|
June 26, 2009
Synthesis, structure-activity relationships, and in vivo evaluation of N3-phenylpyrazinones as novel corticotropin-releasing factor-1 (CRF1) receptor antagonists
Richard A Hartz, Vijay T Ahuja, Argyrios G Arvanitis, et al.
Page
of 19
Search research articles
Search
Showing results (181-190 of 190) with videos related to
Sort By:
Page
of 19
You have reached the last page of results.
This site can display upto 190 results.
Bioorganic & Medicinal Chemistry
|
May 16, 2006
Synthesis and evaluation of 5,5-diphenylimidazolones as potent human neuropeptide Y5 receptor antagonists
Kevin W Gillman, Mendi A Higgins, Graham S Poindexter, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 30, 2009
Conformationally restricted homotryptamines. Part 5: 3-(trans-2-aminomethylcyclopentyl)indoles as potent selective serotonin reuptake inhibitors
Derek J Denhart, Jeffrey A Deskus, Jonathan L Ditta, et al.
Journal of Medicinal Chemistry
|
October 19, 2010
Conformationally restricted homotryptamines. Part 7: 3-cis-(3-aminocyclopentyl)indoles as potent selective serotonin reuptake inhibitors
H Dalton King, Zhaoxing Meng, Jeffrey A Deskus, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 21, 1998
Etoposide in malignant pleural mesothelioma: two phase II trials of the EORTC Lung Cancer Cooperative Group
T Sahmoud, P E Postmus, C van Pottelsberghe, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 30, 2007
Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors
Jeffrey A Deskus, James R Epperson, Charles P Sloan, et al.
Journal of Medicinal Chemistry
|
September 16, 2005
Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors
Ronald J Mattson, John D Catt, Derek J Denhart, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 4, 2007
Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor
H Dalton King, Derek J Denhart, Jeffrey A Deskus, et al.
ACS Medicinal Chemistry Letters
|
April 21, 2016
Discovery and Optimization of Macrocyclic Quinoxaline-pyrrolo-dihydropiperidinones as Potent Pim-1/2 Kinase Inhibitors
Victor J Cee, Frank Chavez, Bradley Herberich, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 27, 2012
[18F](R)-5-chloro-1-(1-cyclopropyl-2-methoxyethyl)-3-(4-(2-fluoroethoxy)-2,5-dimethyl phenylamino)pyrazin-2(1H)-one: introduction of N3-phenylpyrazinones as potential CRF-R1 PET imaging agents
Jeffrey A Deskus, Douglas D Dischino, Ronald J Mattson, et al.
Journal of Medicinal Chemistry
|
June 26, 2009
Synthesis, structure-activity relationships, and in vivo evaluation of N3-phenylpyrazinones as novel corticotropin-releasing factor-1 (CRF1) receptor antagonists
Richard A Hartz, Vijay T Ahuja, Argyrios G Arvanitis, et al.
Page
of 19